SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,752.29 |
| Enterprise Value ($M) | 1,880.26 |
| Book Value ($M) | 596.80 |
| Book Value / Share | 4.54 |
| Price / Book | 2.94 |
| NCAV ($M) | 459.48 |
| NCAV / Share | 3.50 |
| Price / NCAV | 3.81 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.03 |
| Return on Assets (ROA) | 0.03 |
| Return on Equity (ROE) | 0.04 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.91 |
| Current Ratio | 10.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 848.94 |
| Assets | 986.26 |
| Liabilities | 389.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 277.25 |
| Operating Income | 0.89 |
| Net Income | 27.31 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 66.51 |
| Cash from Investing | -18.04 |
| Cash from Financing | -102.02 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Deep Track Capital, LP | |||
| 13G/A | Kynam Capital Management, LP | |||
| 13G/A | BlackRock, Inc. | 16.00 | 0.00 | |
| 13G/A | State Street Corp | 5.90 | -19.01 | |
| 13G/A | Federated Hermes, Inc. | 4.70 | -45.81 | |
| 13G/A | Vanguard Group Inc | 7.18 | 11.16 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 478,217 | 2,408,463 | 19.86 | |
| 329,034 | 1,634,961 | 20.12 | |
| 316,044 | 1,743,742 | 18.12 | |
| 289,832 | 1,270,869 | 22.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DAWN – Day One Biopharmaceuticals, Inc. | DNLI – Denali Therapeutics Inc. |
| DSGN – Design Therapeutics, Inc. | EDIT – Editas Medicine, Inc. |
| ELEV – Elevation Oncology, Inc. |